Quick Answer
Whitehawk Therapeutics, Inc. reported Total Assets of $150.83 million for the year ending 2025.
- Whitehawk Therapeutics, Inc. showed an increase of +114.5% in Total Assets from 2024 to 2025.
- This data is from Whitehawk Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $18.4 thousand | Q3 2013: $14.7 thousand | Q1 2014: $6.5 thousand | Q2 2014: $4.6 thousand | Q3 2014: $17.9 thousand | Q1 2015: $23.3 thousand | Q2 2015: $10.1 thousand | Q3 2015: $6.3 thousand | Q1 2016: $13.2 thousand | Q2 2016: $20.3 thousand | Q3 2016: $7.8 thousand | Q1 2017: $36.28 million | Q2 2017: $29.79 million | Q3 2017: $26.00 million | Q1 2018: $14.73 million | Q2 2018: $69.54 million | Q3 2018: $70.16 million | Q1 2019: $55.06 million | Q2 2019: $49.60 million | Q3 2019: $45.55 million | Q1 2020: $35.70 million | Q2 2020: $45.72 million | Q3 2020: $49.83 million | Q1 2021: $41.16 million | Q2 2021: $37.42 million | Q3 2021: $168.77 million | Q1 2022: $142.32 million | Q2 2022: $128.64 million | Q3 2022: $194.10 million | Q1 2023: $170.65 million | Q2 2023: $151.23 million | Q3 2023: $139.66 million | Q1 2024: $111.07 million | Q2 2024: $101.62 million | Q3 2024: $85.70 million | Q1 2025: $234.00 million | Q2 2025: $180.82 million | Q3 2025: $167.02 million.
- Over the full 14 years of available data (2012 to 2025), Whitehawk Therapeutics, Inc.'s Total Assets has grown by 1,860,390.9%.
- Historical annual values: Fiscal year 2025: $150.83 million | Fiscal year 2024: $70.32 million | Fiscal year 2023: $132.42 million | Fiscal year 2022: $184.24 million | Fiscal year 2021: $157.91 million | Fiscal year 2020: $18.83 million | Fiscal year 2019: $39.94 million | Fiscal year 2018: $64.12 million | Fiscal year 2017: $21.03 million | Fiscal year 2016: $2.40 million | Fiscal year 2015: $18.5 thousand | Fiscal year 2014: $5.3 thousand | Fiscal year 2013: $8.8 thousand | Fiscal year 2012: $8.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: